Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Baker

Showing results (221-230 of 235) with videos related to

Pageof 24
Sort By:
Academic Radiology|December 29, 2000
Comparison of tomosynthesis methods used with digital mammographyS Suryanarayanan, A Karellas, S Vedantham, et al.
American Journal of Public Health|July 8, 1999
Back injury in municipal workers: a case-control studyA H Myers, S P Baker, G Li, et al.
Circulation Research|December 1, 1996
Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranesL Belardinelli, J C Shryock, J Ruble, et al.
Brain Research|December 15, 1987
Phorbol esters inhibit agonist-stimulated phosphoinositide hydrolysis in neuronal primary culturesR A Gonzales, P H Greger, S P Baker, et al.
Lancet (London, England)|June 28, 1975
Alcohol intoxication and serum osmolalityH R Champion, S P Baker, C Benner, et al.
Circulation|August 26, 1998
A2A-adenosine receptor reserve for coronary vasodilationJ C Shryock, S Snowdy, P G Baraldi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cellsL Belardinelli, J C Shryock, Y Zhang, et al.
Journal of Medicinal Chemistry|June 6, 1997
Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthineJ R Pfister, L Belardinelli, G Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonistsZ Gao, Z Li, S P Baker, et al.
Chest|July 1, 1985
Ejection fraction and heart rate correlate with diastolic peak filling rate at rest and during exerciseJ A Bianco, A W Filiberti, S P Baker, et al.
Pageof 24

Showing results (221-230 of 235) with videos related to

Sort By:
Pageof 24
Academic Radiology|December 29, 2000
Comparison of tomosynthesis methods used with digital mammographyS Suryanarayanan, A Karellas, S Vedantham, et al.
American Journal of Public Health|July 8, 1999
Back injury in municipal workers: a case-control studyA H Myers, S P Baker, G Li, et al.
Circulation Research|December 1, 1996
Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranesL Belardinelli, J C Shryock, J Ruble, et al.
Brain Research|December 15, 1987
Phorbol esters inhibit agonist-stimulated phosphoinositide hydrolysis in neuronal primary culturesR A Gonzales, P H Greger, S P Baker, et al.
Lancet (London, England)|June 28, 1975
Alcohol intoxication and serum osmolalityH R Champion, S P Baker, C Benner, et al.
Circulation|August 26, 1998
A2A-adenosine receptor reserve for coronary vasodilationJ C Shryock, S Snowdy, P G Baraldi, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cellsL Belardinelli, J C Shryock, Y Zhang, et al.
Journal of Medicinal Chemistry|June 6, 1997
Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthineJ R Pfister, L Belardinelli, G Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 16, 2001
Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonistsZ Gao, Z Li, S P Baker, et al.
Chest|July 1, 1985
Ejection fraction and heart rate correlate with diastolic peak filling rate at rest and during exerciseJ A Bianco, A W Filiberti, S P Baker, et al.
Pageof 24